
Monica E. Millner
Examiner (ID: 17239, Phone: (571)270-7507 , Office: P/3632 )
| Most Active Art Unit | 3632 |
| Art Unit(s) | 3632, 3508, 3627 |
| Total Applications | 1497 |
| Issued Applications | 1151 |
| Pending Applications | 94 |
| Abandoned Applications | 283 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14649491
[patent_doc_number] => 20190231874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => (BACTERIO)CHLOROPHYLL PHOTOSENSITIZERS FOR TREATMENT OF EYE DISEASES AND DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/196537
[patent_app_country] => US
[patent_app_date] => 2018-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16196537
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/196537 | (Bacterio)chlorophyll photosensitizers for treatment of eye diseases and disorders | Nov 19, 2018 | Issued |
Array
(
[id] => 14715443
[patent_doc_number] => 20190248785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG
[patent_app_type] => utility
[patent_app_number] => 16/194504
[patent_app_country] => US
[patent_app_date] => 2018-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 149579
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16194504
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/194504 | SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG | Nov 18, 2018 | Abandoned |
Array
(
[id] => 17634968
[patent_doc_number] => 11345680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Method for producing bispyrrolidine compounds
[patent_app_type] => utility
[patent_app_number] => 16/766678
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4409
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766678 | Method for producing bispyrrolidine compounds | Nov 12, 2018 | Issued |
Array
(
[id] => 14624475
[patent_doc_number] => 20190225605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => DEUTERATED PALBOCICLIB
[patent_app_type] => utility
[patent_app_number] => 16/189304
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16189304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/189304 | DEUTERATED PALBOCICLIB | Nov 12, 2018 | Abandoned |
Array
(
[id] => 14018909
[patent_doc_number] => 20190071448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-07
[patent_title] => PYRAZOLO[1,5-A]PYRAZIN-4-YL DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/181596
[patent_app_country] => US
[patent_app_date] => 2018-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16181596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/181596 | Pyrazolo[1,5-a]pyrazin-4-yl derivatives | Nov 5, 2018 | Issued |
Array
(
[id] => 14960519
[patent_doc_number] => 20190307737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-10
[patent_title] => NOVEL PIPERIDINE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/179122
[patent_app_country] => US
[patent_app_date] => 2018-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16179122
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/179122 | NOVEL PIPERIDINE DERIVATIVES | Nov 1, 2018 | Abandoned |
Array
(
[id] => 19027266
[patent_doc_number] => 11926613
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Kinase inhibitors for the treatment of central and peripheral nervous system disorders
[patent_app_type] => utility
[patent_app_number] => 16/760365
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 22055
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16760365
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/760365 | Kinase inhibitors for the treatment of central and peripheral nervous system disorders | Oct 30, 2018 | Issued |
Array
(
[id] => 16312259
[patent_doc_number] => 20200290997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => BTK INHIBITOR COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/758219
[patent_app_country] => US
[patent_app_date] => 2018-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758219
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758219 | BTK inhibitor compounds | Oct 29, 2018 | Issued |
Array
(
[id] => 13986375
[patent_doc_number] => 20190062345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
[patent_app_type] => utility
[patent_app_number] => 16/170898
[patent_app_country] => US
[patent_app_date] => 2018-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 2411
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16170898
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/170898 | HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS | Oct 24, 2018 | Abandoned |
Array
(
[id] => 18620372
[patent_doc_number] => 11753400
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-12
[patent_title] => D-amino acid oxidase inhibitors and therapeutic uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/757327
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 27108
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16757327
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/757327 | D-amino acid oxidase inhibitors and therapeutic uses thereof | Oct 17, 2018 | Issued |
Array
(
[id] => 17697068
[patent_doc_number] => 11370778
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases
[patent_app_type] => utility
[patent_app_number] => 16/756416
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24722
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 336
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756416
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756416 | Bis(pentahydroxyhexyl)amino substituted 2-{[(3-amino-pyrazin-2-yl)formamido]methyl}-1H-1,3-benzodiazol-3-ium derivatives as ENaC inhibitors for treating respiratory diseases | Oct 16, 2018 | Issued |
Array
(
[id] => 16383172
[patent_doc_number] => 10807994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Heterocyclic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/155841
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64476
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155841
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155841 | Heterocyclic compounds and uses thereof | Oct 8, 2018 | Issued |
Array
(
[id] => 16383307
[patent_doc_number] => 10808129
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Methine dyes
[patent_app_type] => utility
[patent_app_number] => 16/155111
[patent_app_country] => US
[patent_app_date] => 2018-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7093
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16155111
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/155111 | Methine dyes | Oct 8, 2018 | Issued |
Array
(
[id] => 14158691
[patent_doc_number] => 20190106448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-11
[patent_title] => MANGANESE (III) CATALYZED C--H AMINATIONS
[patent_app_type] => utility
[patent_app_number] => 16/153178
[patent_app_country] => US
[patent_app_date] => 2018-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38176
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16153178
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/153178 | Manganese (III) catalyzed C--H aminations | Oct 4, 2018 | Issued |
Array
(
[id] => 13901603
[patent_doc_number] => 20190040006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/148798
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148798 | Selective androgen receptor modulators (SARMs) and uses thereof | Sep 30, 2018 | Issued |
Array
(
[id] => 18216395
[patent_doc_number] => 11591317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Organic molecules for use in optoelectronic devices
[patent_app_type] => utility
[patent_app_number] => 16/755314
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 10809
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 849
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755314
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/755314 | Organic molecules for use in optoelectronic devices | Sep 30, 2018 | Issued |
Array
(
[id] => 15977877
[patent_doc_number] => 10669246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Benzothiazol compounds and methods using the same for treating neurodegenerative disorders
[patent_app_type] => utility
[patent_app_number] => 16/148265
[patent_app_country] => US
[patent_app_date] => 2018-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31093
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16148265
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/148265 | Benzothiazol compounds and methods using the same for treating neurodegenerative disorders | Sep 30, 2018 | Issued |
Array
(
[id] => 16176836
[patent_doc_number] => 20200223804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => CRYSTAL
[patent_app_type] => utility
[patent_app_number] => 16/650390
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4973
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650390 | Crystalline substituted pyrazines as PGI2 receptor agonists | Sep 26, 2018 | Issued |
Array
(
[id] => 17680955
[patent_doc_number] => 11365194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Analgesic drug using PAC1 receptor antagonistic drug
[patent_app_type] => utility
[patent_app_number] => 16/650133
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9989
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650133
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650133 | Analgesic drug using PAC1 receptor antagonistic drug | Sep 26, 2018 | Issued |
Array
(
[id] => 13826371
[patent_doc_number] => 20190016670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-17
[patent_title] => TRIFLUOROMETHOXYLATION OF ARENES VIA INTRAMOLECULAR TRIFLUOROMETHOXY GROUP MIGRATION
[patent_app_type] => utility
[patent_app_number] => 16/133297
[patent_app_country] => US
[patent_app_date] => 2018-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49741
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16133297
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/133297 | Trifluoromethoylation of arenes via intramolecular trifluoromethoxy group migration | Sep 16, 2018 | Issued |